Show simple item record

Family History of Exceptional Longevity Is Associated with Lower Serum Uric Acid Levels in A shkenazi J ews

dc.contributor.authorLai, Jennifer Yi‐chunen_US
dc.contributor.authorAtzmon, Gilen_US
dc.contributor.authorMelamed, Michal L.en_US
dc.contributor.authorHostetter, Thomas H.en_US
dc.contributor.authorCrandall, Jill P.en_US
dc.contributor.authorBarzilai, Niren_US
dc.contributor.authorBitzer, Markusen_US
dc.date.accessioned2012-05-21T15:49:24Z
dc.date.available2013-06-11T19:15:53Zen_US
dc.date.issued2012-04en_US
dc.identifier.citationLai, Jennifer Yi‐chun ; Atzmon, Gil; Melamed, Michal L.; Hostetter, Thomas H.; Crandall, Jill P.; Barzilai, Nir; Bitzer, Markus (2012). "Family History of Exceptional Longevity Is Associated with Lower Serum Uric Acid Levels in A shkenazi J ews." Journal of the American Geriatrics Society 60(4): 745-750. <http://hdl.handle.net/2027.42/91205>en_US
dc.identifier.issn0002-8614en_US
dc.identifier.issn1532-5415en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/91205
dc.publisherNational Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseasesen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherUric Aciden_US
dc.subject.otherKidney Functionen_US
dc.subject.otherLongevityen_US
dc.titleFamily History of Exceptional Longevity Is Associated with Lower Serum Uric Acid Levels in A shkenazi J ewsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid22429185en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/91205/1/jgs3902.pdf
dc.identifier.doi10.1111/j.1532-5415.2012.03902.xen_US
dc.identifier.sourceJournal of the American Geriatrics Societyen_US
dc.identifier.citedreferenceWard PJ. Parent‐offspring regression and extreme environments. Heredity 1994; 72: 574 – 581.en_US
dc.identifier.citedreferenceAtzmon G, Rincon M, Rabizadeh P et al. Biological evidence for inheritance of exceptional longevity. Mech Ageing Dev 2005; 126: 341 – 345.en_US
dc.identifier.citedreferenceBarzilai N, Rossetti L, Lipton RB. Einstein's Institute for Aging Research: collaborative and programmatic approaches in the search for successful aging. Exp Gerontol 2004; 39: 151 – 157.en_US
dc.identifier.citedreferenceBarzilai N, Gabriely I, Gabriely M et al. Offspring of centenarians have a favorable lipid profile. J Am Geriatr Soc 2001; 49: 76 – 79.en_US
dc.identifier.citedreferenceBarzilai N, Atzmon G, Schechter C et al. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 2003; 290: 2030 – 2040.en_US
dc.identifier.citedreferenceAtzmon G, Barzilai N, Hollowell JG et al. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 2009; 94: 1251 – 1254.en_US
dc.identifier.citedreferenceGulbrandsen CL, Morton NE, Rao DC et al. Determinants of plasma uric acid. Hum Genet 1979; 50: 307 – 312.en_US
dc.identifier.citedreferenceEdwards NL. The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med 2008; 75 ( Suppl 5 ): S13 – S16.en_US
dc.identifier.citedreferenceU.S. Renal Data System. 2010 Annual Data Report: Atlas of End‐Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010.en_US
dc.identifier.citedreferenceCoresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038 – 2047.en_US
dc.identifier.citedreferenceChobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206 – 1252.en_US
dc.identifier.citedreferenceLevey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604 – 612.en_US
dc.identifier.citedreferenceLevey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461 – 470.en_US
dc.identifier.citedreferenceCockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31 – 41.en_US
dc.identifier.citedreferenceMatthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta‐cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412 – 419.en_US
dc.identifier.citedreferenceGeloneze B, Repetto EM, Geloneze SR et al. The threshold value for insulin resistance (HOMA‐IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006; 72: 219 – 220.en_US
dc.identifier.citedreferenceBaxmann AC, Ahmed MS, Marques NC et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008; 3: 348 – 354.en_US
dc.identifier.citedreferenceKim SY, Guevara JP, Kim KM et al. Hyperuricemia and coronary heart disease: a systematic review and meta‐analysis. Arthritis Care Res (Hoboken) 2010; 62: 170 – 180.en_US
dc.identifier.citedreferenceBotev R, Mallie JP, Couchoud C et al. Estimating glomerular filtration rate: Cockcroft‐Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol 2009; 4: 899 – 906.en_US
dc.identifier.citedreferenceFliser D. Assessment of renal function in elderly patients. Curr Opin Nephrol Hypertens 2008; 17: 604 – 608.en_US
dc.identifier.citedreferenceFried LF, Shlipak MG, Crump C et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 2003; 41: 1364 – 1372.en_US
dc.identifier.citedreferenceFried LF. Creatinine and cystatin C: What are the values? Kidney Int 2009; 75: 578 – 580.en_US
dc.identifier.citedreferenceBorges RL, Ribeiro AB, Zanella MT et al. Uric acid as a factor in the metabolic syndrome. Curr Hypertens Rep 2010; 12: 113 – 119.en_US
dc.identifier.citedreferenceOda M, Satta Y, Takenaka O et al. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002; 19: 640 – 653.en_US
dc.identifier.citedreferenceCutler RG. Urate and ascorbate: their possible roles as antioxidants in determining longevity of mammalian species. Arch Gerontol Geriatr 1984; 3: 321 – 348.en_US
dc.identifier.citedreferenceFang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow‐up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404 – 2410.en_US
dc.identifier.citedreferenceKim SY, Guevara JP, Kim KM et al. Hyperuricemia and risk of stroke: a systematic review and meta‐analysis. Arthritis Rheum 2009; 61: 885 – 892.en_US
dc.identifier.citedreferenceDehghan A, van Hoek M, Sijbrands EJ et al. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008; 31: 361 – 362.en_US
dc.identifier.citedreferenceObermayr RP, Temml C, Gutjahr G et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008; 19: 2407 – 2413.en_US
dc.identifier.citedreferenceAtzmon G, Schechter C, Greiner W et al. Clinical phenotype of families with longevity. J Am Geriatr Soc 2004; 52: 274 – 277.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.